USPTO serial 79307644
Q QUBIT PHARMACEUTICALS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 24, 2022
- Examiner
- BERNS, LEE ANNE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Q QUBIT PHARMACEUTICALS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Steven J. Solomon
Steven J. Solomon Tucker Ellis LLP950 Main Avenue, Suite 1100Cleveland, OH 44113United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Collection of information, particularly commercial, scientific and health information, namely, compilation of scientific, health, medical and pharmacology information into computer databases; collection of data, namely, commercial, scientific and health data, for business purposes; providing an on-line searchable database featuring information and business intelligence in the fields of medicine, pharmaceuticals and life sciences; subscription to all information media, namely, subscription to an information media package; collection and systematization of scientific, health, medical and pharmacology information in computer databases; advice regarding communication being public relations advice in the fields of health, medicine, pharmacology and the treatment of illnesses; demonstration of goods for promotional or advertising purposes in the fields of health, medicine, pharmacology and the treatment of illnesses; provision of information on products for customers, namely, provision of consumer information and advice regarding the selection of products and items to be purchased in the fields of health, medicine, pharmacology and the treatment of illnesses; management of files and records, namely, computerized file management, related to the health status of individuals, drug molecules for medical use and pharmaceutical formulations for medical use, as well as computerized file management related to medicines and medical research; provision of information relating to data processing services of health and medical data; negotiation and conclusion of commercial transactions for others; organization of business meetings, namely, business meeting planning, particularly, with a view to establishing commercial collaborations in the health and medical fields; statistical information compilation services of health and medical information for business purposes; data processing services in the fields of health, medicine, pharmacology and the treatment of illnesses; retail store services featuring medical software, downloadable medical software and medical software applications including for mobile telephones, tablet computers and other electronic mobile devices, computer files and machine readable data files, for medical and non-medical research and analysis; retail store services featuring virtual goods, namely, medical software component parts being software applications, medical software enhancements, access codes and software extensions for unlocking content and additional software elements for use in medical software; business administration services for the licensing of products and of services of others in the fields of health, medicine, pharmacology and the treatment of illnesses; commercial intermediary services in the nature of business networking of establishing commercial and professional contact connections in the fields of health, medicine, pharmacology and the treatment of illnesses; arranging online subscription services to an online database for capturing, collecting, analyzing, processing and using data, particularly health and medical data, for business purposes; information and advice concerning all the aforesaid services; compilation of scientific and technical information, namely, compilation of scientific information into computer databases; compilation of information related to people's health and to medicines, namely, compilation of medical information into computer databases; all the aforesaid services provided in connection with or relating to scientific research in the health and medical fields | ACTIVE | — |
| 042 | Scientific research; scientific analysis of molecules in the field of developing treatments and medicines; medical research services, namely, computerized testing and analysis of medical compounds, medicines and molecules with the purpose of discovering new treatments or improving and optimizing of existing treatments; quality control of medical compounds and medicines for others;, analyzing of scientific and technical data and of scientific and technical analyses being scientific research; design of technical and scientific studies, namely, design, and planning of scientific research studies; design, development, programming, configuration, installation, maintenance, updating and testing of algorithms and software, particularly for artificial intelligence and for computerized decision aid tools that help individuals and organizations make choices and take decisions by ranking, prioritizing or choosing from a number of options, in the fields of health, medicine, pharmacology and the treatment of illnesses; design, development, programming, configuration, installation, maintenance, updating and testing of algorithms and computer software and software platforms that are used for consulting, analyzing, exchanging and sharing data, particularly in a collaborative work environment, for use in in the fields of health, medicine, pharmacology and the treatment of illnesses; design, development, composition, updating and testing of new medicines and new medicine formulas being scientific research; computer database design and development, namely, designing databases for use in the fields of health, medicine, pharmacology and the treatment of illnesses; development of computer platforms; scientific and technical project study being scientific study and research in the fields of medicine, pharmacology and the treatment of illnesses; engineering design services, including computer assisted; estimates and analyses in the technological fields provided by engineers, namely, conducting engineering surveys; evaluation of the performance of medical treatments being quality control for others; design, development and programming of artificial intelligence software for use in the fields of health, medicine, pharmacology and the treatment of illnesses; advice in the field of technological development, namely, development of new technology for others in the fields of health, medicine, pharmacology and the treatment of illnesses; software as a service (SaaS) services featuring software for processing and analyzing data in the fields of health, medicine, pharmacology and the treatment of illnesses; computer project management in the field of electronic data processing; rental of computer software in the fields of health, medicine, pharmacology and the treatment of illnesses; platforms as a service (PAAS) featuring computer software platforms for artificial intelligence, namely, computer software platforms using artificial intelligence for data management, administering medication, molecule and compound modelling and virtual evaluation and testing in the fields of health, medicine, pharmacology and the treatment of illnesses; provision of information relating to scientific technology, namely, scientific research information in the field of pharmaceuticals; provision of temporary use of online non-downloadable software for data processing and data analysis, namely, non-downloadable software for data processing and data analysis in the fields of health, medicine, pharmacology and the treatment of illnesses; preparation of technical and scientific reports, namely, providing technical and scientific information in the field of medical research; scientific research services; research and development services relating to the processing of medical data for third parties; information and advice concerning all the aforesaid services; all the aforesaid services provided in connection with or relating to scientific research in the health and medical fields | ACTIVE | — |
| 044 | Medical and paramedical analysis for diagnosis and treatment of persons; medical data analysis for diagnostic purposes and treatment of persons and animals; medical and paramedical assistance being medical services; establishment of health check-ups, namely, providing medical examination services; conducting of medical examinations and evaluations on the health of persons and on the impact of medicines thereon for medical diagnostic and treatment purposes, not including medical research; medical counseling in the medical, paramedical, health and physical well-being field of individuals; professional consultancy in connection with health being consulting services in the field of medical care; medical and paramedical screening for diagnostic and treatment purposes; preparation of medical reports and medical recommendations, namely, providing medical information to medical professionals and drug makers in the form of reports in the field of medicine, pharmacology and the treatment of illnesses; medical and paramedical examinations; rental of medical equipment; planning and supervision of medical and paramedical treatment of persons, being medical treatment planning on medical protocols for patient treatment; preparation of medical and paramedical prescriptions, namely, drafting of prescriptions by doctors; carrying out disease diagnostics, namely, medical analysis for the diagnosis and treatment of persons; advisory services in the field of health care being consultancy services relating to health care; medical diagnosis services for the diagnosis and treatment of persons; telemedicine services; information and advice concerning all the aforesaid services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Qubit Pharmaceuticals
- Other trademarks owned by Qubit Pharmaceuticals
- Other trademarks owned by Qubit Pharmaceuticals
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named Q QUBIT PHARMACEUTICALS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 7, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 7, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| May 7, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 7, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 7, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 7, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 2, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 7, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 7, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 24, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 24, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 24, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 8, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 8, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 7, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 16, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 16, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 16, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 2, 2022 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 31, 2022 | ALIE | ASSIGNED TO LIE | — |
| Jan 31, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 31, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 31, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 31, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 31, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 24, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 23, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 23, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 10, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jun 20, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 2, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 2, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 27, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 26, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 12, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 6, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 2, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 1, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |